Histrelin

In the US, Histrelin (histrelin systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Precocious Puberty and Prostate Cancer.

US matches:

• Histrelin Implant


• Histrelin Subcutaneous


• Histrelin acetate Subcutaneous


• Histrelin


• Histrelin Acetate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CA03

CAS registry number (Chemical Abstracts Service)

0076712-82-8

Chemical Formula

C66-H86-N18-O12

Molecular Weight

1323

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N²-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide (WHO)

Foreign Names

• Histrelinum (Latin)
• Histrelin (German)
• Histréline (French)
• Histrelina (Spanish)

Generic Names

• Histrelin (OS: USAN)
• ORF 17070 (IS: Ortho)
• RWJ 17070 (IS)

Brand Names

• Supprelin
  Indevus, United States



• Vantas
  Endo, United States; Orion, Germany; Orion, United Kingdom; Orion Corporation, Spain; Valera, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.